Catalysts for Massachusetts Eye and Ear Infirmary
3 tracked
Apr 29, 2026
phase 2 completion
Massachusetts Eye and Ear Infirmary — N-acetylcysteine (Phase II Trial Completion)
N-acetylcysteine
→
Apr 1, 2026
grant
MASSACHUSETTS EYE AND EAR INFIRMARY — Elucidating the molecular mechanisms of secondary cone degeneration in models...
Massachusetts Eye and Ear Infirmary
→
Sep 11, 2025
grant
MASSACHUSETTS EYE AND EAR INFIRMARY — In-silico screen and in-vivo evaluation of FDA-approved drugs to treat noise-...
Massachusetts Eye and Ear Infirmary
→